Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim–sulfamethoxazole: lessons from an observational cohort study
Open Access
- 15 October 2015
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 44 (3) , 291-299
Abstract
The recommended treatment of Pneumocystis jirovecii pneumonia (PCP) is high-dose trimethoprim–sulfamethoxazole (TMP–SMX) in an equivalent of TMP 15–20 mg/kg/day and SMX 75–100 mg/kg/day for 2 or 3 weeks. High rates of adverse events are reported with this dose, which raises the question if lower doses are possible.Keywords
This publication has 34 references indexed in Scilit:
- Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort studyThorax, 2009
- Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patientsScandinavian Journal of Infectious Diseases, 2009
- Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003BMC Infectious Diseases, 2008
- Current insights into the biology and pathogenesis of Pneumocystis pneumoniaNature Reviews Microbiology, 2007
- Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samplesJournal of Medical Microbiology, 2006
- Pneumocystis carinii Pneumonia in HIV-Infected Patients in the HAART EraAIDS Patient Care and STDs, 2003
- Analysis of Underlying Diseases and Prognosis Factors Associated with Pneumocystis carinii Pneumonia in Immunocompromised HIV-Negative PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Survival of Patients with AIDS, after Diagnosis ofPneumocystis cariniiPneumonia, in the United StatesThe Journal of Infectious Diseases, 2001
- Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus (HIV)—Positive and HIV-Negative Immunocompromised PatientsClinical Infectious Diseases, 1999
- Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patientsAIDS, 1992